A Multicenter Phase II Trial of Trastuzumab (Herceptin) Continuation in Combination With 2nd-line Chemotherapies After Progression on a 1st-line Chemotherapy Combined With Trastuzumab in Patients With HER2 Positive Metastatic Breast Cancer (Treatment Beyond Progression, TBP)
Phase of Trial: Phase II
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Trastuzumab (Primary) ; Antineoplastics
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors Roche
- 19 Sep 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 10 Aug 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 18 Apr 2011 There are 45 centres taking part in the study, according to ClinicalTrials.gov.